Target intelligence / Profile preview

LIM domain-containing protein 1 (LIMD1)

Target
LIMD1
Molecular classification
Scaffold protein, Transcription regulator, Zyxin family protein, LIM domain protein, Other
01

Overview

LIM domain-containing protein 1 (LIMD1) is a tumor suppressor encoded on chromosome 3p21.3 that belongs to the Zyxin family of LIM-domain proteins. It acts as a multifunctional scaffold involved in transcriptional regulation, cell cycle control, and protein complex assembly. LIMD1 exerts key tumor-suppressive effects by binding to and enhancing the function of retinoblastoma protein (pRB), repressing E2F1-driven gene expression, and inhibiting cell proliferation. It also participates in the microRNA-induced silencing complex (miRISC) and facilitates the degradation of HIF-1α, thus modulating hypoxic response. Downregulation or loss of LIMD1 expression is observed in various solid tumors, including lung, breast, and head and neck cancers. While not an enzyme, transporter, or receptor, LIMD1 is an important mediator of protein-protein interactions central to oncogenic processes and presents a proposed synthetic lethal vulnerability for targeted therapy in LIMD1-deficient tumors.

Other names
LIM domain-containing 1LIMD1LIM domains containing 1LIMD1 proteinLIM domains-containing protein 1
02

Mechanism of action

Restoration or mimicry of LIMD1 function to reactivate tumor suppressor effects; Inhibition of downstream pro-tumorigenic pathways arising from LIMD1 loss (preclinical/synthetic lethality research)

03

Biological functions

Transcription corepressionModulation of cell cycle progressionRegulation of E2F-driven transcriptionTumor suppressionmicroRNA-induced silencing complex (miRISC) assemblyRegulation of hypoxic response (degradation of HIF-1α)Actin filament assemblyCytoskeletal organizationCell differentiationNegative regulation of Hippo signaling pathwayRegulation of osteoblast and osteoclast function
04

Disease associations

Cancer (especially lung, breast, head and neck squamous cell carcinoma, ovarian, renal, gastric cancers)Hematologic cancerMyopathy, X-linked, with postural muscle atrophy
05

Safety considerations

As a tumor suppressor scaffold protein, direct 'activation' is challenging in drug development; loss-of-function concerns may limit direct pharmacological intervention; synthetic lethality and tissue-specific effects may present therapeutic and safety challenges
06

Interacting drugs

No direct approved drugs known to target LIMD1 as a primary pharmacological target; indirect targeting through synthetic lethality approaches has been proposed for LIMD1-deficient tumors (e.g., NSCLC)
07

Biomarkers

LIMD1 expression level (as a biomarker for tumor suppressor function and patient stratification in various cancers, especially lung cancer)LIMD1 promoter methylation status

Beyond the preview

Go deeper on LIM domain-containing protein 1 (LIMD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIM domain-containing protein 1 (LIMD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call